Related Experiment Video
Updated: Jul 29, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease
Jin Chen1, Yanping Hao1, Ping Xu1
1Department of Gastroenterology, The First People's Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical University, Yancheng, Jiangsu, China.
Background:
Hepatocyte lipotoxicity mediated by sphingolipids was considered one of important factors in NAFLD development. Knocking out key enzymes for sphingolipids synthesis, such as DES-1, SPHK1 and CerS6, could reduce hepatocyte lipotoxicity and improve NAFLD progression. Previous studies showed that roles of CerS5 and CerS6 in sphingolipids metabolism were similar, but the role of CerS5 was controversial in NAFLD development. This study aimed to clarify the role and mechanism of CerS5 in NAFLD development.
Methods:
Hepatocyte conditional CerS5 knockout (CerS5 CKO) and wild type (WT) mice were fed with standard control diet (SC) and choline-deficient, l-amino acid-defined, high-fat diet (CDAHFD) and then divided into four groups: CerS5 CKO-SC, CerS5 CKO-CDAHFD, WT-SC and WT-CDAHFD. RT-PCR, IHC and WB were used to analyze the expression of inflammatory, fibrosis and bile acids (BA) metabolism factors. RNA-seq was used to analyze differences of transcriptional levels of liver molecules among the four groups. Metabolomics was used to measured differences of hepatic BAs among the four groups.
Results:
Hepatocyte specific knockout of CerS5 did not increase or reduce the severity of 8-weeks CDAHFD induced hepatic steatosis and inflammation, but significantly worsened the progression of liver fibrosis in these mice. At the molecular level, hepatocyte specific knockout of CerS5 did not increase or reduce expression of hepatic inflammatory factors: CD68, F4/80 and MCP-1, but increased expression of hepatic fibrosis factors: α-SMA, COL1α and TGF-β in mice fed with CDAHFD. Transcriptome analysis showed that hepatocyte specific knockout of CerS5 significantly decreased the expression of hepatic cyp27a1, and decreased expression of cyp27a1 was further validated by RT-PCR and WB. Considering that cyp27a1 was a key enzyme in the alternative pathway of BA synthesis, we further found that hepatic BA pools in CerS5 CKO mice were more conducive to the progression of liver fibrosis, which were characterized by elevated hydrophobic 12α-OH BAs and decreased hydrophilic non-12α-OH BAs.
Conclusion:
CerS5 played an important role in the progression of NAFLD related fibrosis, and hepatocyte specific knockout of CerS5 accelerated the progression of NAFLD related fibrosis, which was possibly due to the inhibition of BA synthesis alternative pathway by knocking out hepatocyte CerS5.
Insights
Ceramide synthase 5 (CerS5) knockout in hepatocytes worsened non-alcoholic fatty liver disease (NAFLD) fibrosis by inhibiting bile acid synthesis. This study clarifies CerS5
Area of Science:
- Hepatology
- Metabolic diseases
- Molecular biology
Background:
- Sphingolipid metabolism is implicated in non-alcoholic fatty liver disease (NAFLD) pathogenesis.
- Ceramide synthase 5 (CerS5) has a controversial role in NAFLD.
- Clarifying CerS5's role is crucial for understanding NAFLD progression.
Purpose of the Study:
- To elucidate the role and mechanism of CerS5 in NAFLD development.
- To investigate the impact of hepatocyte-specific CerS5 knockout on NAFLD progression.
Main Methods:
- Generated hepatocyte conditional CerS5 knockout (CerS5 CKO) and wild-type (WT) mice.
- Utilized high-fat diet (CDAHFD) to induce NAFLD.
- Employed RT-PCR, IHC, WB, RNA-seq, and metabolomics for molecular and metabolic analyses.
Main Results:
- Hepatocyte CerS5 knockout did not alter steatosis or inflammation but significantly worsened liver fibrosis.
- Knockout increased expression of fibrosis markers (α-SMA, COL1α, TGF-β) and decreased Cyp27a1 expression.
- Altered bile acid profiles in CerS5 CKO mice showed increased hydrophobic and decreased hydrophilic bile acids, favoring fibrosis.
Conclusions:
- CerS5 is critical in promoting NAFLD-related fibrosis progression.
- Hepatocyte CerS5 deficiency accelerates fibrosis, likely by inhibiting the alternative bile acid synthesis pathway.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...